Government of Serbia and Pfizer Partners in BIO4 Campus
Source: Beta
Tuesday, 26.09.2023.
15:52
Comments
(Photo: Bio4.rs/Screenshot)
That center will gather the academic community, the private sector, startups and all other relevant actors in order to make Serbia known for its innovations and science, says the press release by Pfizer. At the signing, the prime minister of Serbia, Ana Brnabic, expressed the satisfaction over the fact that one of the biggest global pharmaceutical companies had recognized the Government of Serbia’s activities related to scientific innovations.
– The cooperation with Pfizer and today’s signing of the Memorandum of Understanding is fully in line with the Government of Serbia’s choice to invest in science, innovations, use of modern technologies, biotechnology, and most importantly, in the implementation of one of the priority projects in this government’s mandate, which is the BIO4 Campus – Brnabic said.
She estimated that the signed document provided room for a further increase of the competitiveness of Serbia’s economy, with the focus on Pfizer’s engagement on increasing the number of clinical studies, education, promotion, sharing of knowledge and cooperation with institutes and faculties in Serbia in research and development.
The regional director of Pfizer, Mohamed Hammam, emphasized the importance of the cooperation between the private and public sectors.
– As a company which has been unstoppable day after day in its search for innovative discoveries which change the lives of patients, dedicated to finding solutions in order to reach every one of them, relying on science, which always wins, we are very happy that we will continue that mission through close cooperation with the state of Serbia – he said.
Pfizer is one of the leading innovative biopharmaceutical companies in the world, founded in 1849 in New York.
Tags:
Government of Serbia
Pfizer
BIO4 Campus
Mohamed Hammam
Memorandum of Understanding
partnership
Comments
Your comment
Most Important News
Full information is available only to commercial users-subscribers and it is necessary to log in.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno,
uz konsultacije sa našim ekspertima.